ramipril-5 capsule
sivem pharmaceuticals ulc - ramipril - capsule - 5mg - ramipril 5mg - angiotensin-converting enzyme inhibitors
ramipril-10 capsule
sivem pharmaceuticals ulc - ramipril - capsule - 10mg - ramipril 10mg - angiotensin-converting enzyme inhibitors
ramipril capsule
laboratoire riva inc. - ramipril - capsule - 15mg - ramipril 15mg - angiotensin-converting enzyme inhibitors
ramipril capsule
altamed pharma - ramipril - capsule - 1.25mg - ramipril 1.25mg - angiotensin-converting enzyme inhibitors
ramipril capsule
altamed pharma - ramipril - capsule - 2.5mg - ramipril 2.5mg - angiotensin-converting enzyme inhibitors
ramipril capsule
altamed pharma - ramipril - capsule - 5mg - ramipril 5mg - angiotensin-converting enzyme inhibitors
ramipril capsule
altamed pharma - ramipril - capsule - 10mg - ramipril 10mg - angiotensin-converting enzyme inhibitors
ramipril capsule
altamed pharma - ramipril - capsule - 15mg - ramipril 15mg - angiotensin-converting enzyme inhibitors
felodipine tablet, film coated, extended release
wockhardt limited - felodipine (unii: ol961r6o2c) (felodipine - unii:ol961r6o2c) - felodipine 2.5 mg
felodipine tablet, film coated
carlsbad technology, inc. - felodipine (unii: ol961r6o2c) (felodipine - unii:ol961r6o2c) - felodipine extended-release tablets, usp are indicated for the treatment of hypertension, to lower blood pressure. lowering blood pressure lowers the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including felodipine. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise and limited sodium intake. many patients will require more than one drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high blood pressure education program’s joint nat